tiprankstipranks
Trending News
More News >
Mabpharm Limited (HK:2181)
:2181
Hong Kong Market

Compare Mabpharm Limited (2181) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mabpharm Limited
HK$0.50
HK$2.27B
-76.39
107.55%
Antengene Corporation Limited
HK$5.27
HK$2.68B
-11.24
494.37%
0 Buy
1 Hold
0 Sell
Hold
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$1.93B
238.10
38.89%
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
HK$5.71
HK$1.45B
-14.99
276.82%
SinoMab Bioscience Ltd.
HK$1.39
HK$2.35B
-11.90
72.73%
Immunotech Biopharm Ltd
HK$2.68
HK$1.71B
-6.43
29.32%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2181
Mabpharm Limited
0.55
0.30
120.00%
HK:6996
Antengene Corporation Limited
4.22
3.52
502.86%
HK:1875
TOT BIOPHARM International Co. Ltd.
2.50
0.70
38.89%
HK:2185
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
5.95
4.41
286.36%
HK:3681
SinoMab Bioscience Ltd.
1.71
0.71
71.00%
HK:6978
Immunotech Biopharm Ltd
2.77
0.70
33.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts